283 related articles for article (PubMed ID: 21712017)
1. Innate immunity in type 1 diabetes.
Diana J; Gahzarian L; Simoni Y; Lehuen A
Discov Med; 2011 Jun; 11(61):513-20. PubMed ID: 21712017
[TBL] [Abstract][Full Text] [Related]
2. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
Cardell SL
Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
[TBL] [Abstract][Full Text] [Related]
3. Regulation of type 1 diabetes by NKT cells.
Novak J; Griseri T; Beaudoin L; Lehuen A
Int Rev Immunol; 2007; 26(1-2):49-72. PubMed ID: 17454264
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
[TBL] [Abstract][Full Text] [Related]
5. A role for innate immunity in type 1 diabetes?
Beyan H; Buckley LR; Yousaf N; Londei M; Leslie RD
Diabetes Metab Res Rev; 2003; 19(2):89-100. PubMed ID: 12673777
[TBL] [Abstract][Full Text] [Related]
6. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
[TBL] [Abstract][Full Text] [Related]
7. [Regulatory role of NKT cells in the prevention of type 1 diabetes].
Ghazarian L; Simoni Y; Pingris K; Beaudoin L; Lehuen A
Med Sci (Paris); 2013; 29(8-9):722-8. PubMed ID: 24005626
[TBL] [Abstract][Full Text] [Related]
8. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV
Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387
[TBL] [Abstract][Full Text] [Related]
9. Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.
Serreze DV; Niens M; Kulik J; Dilorenzo TP
Methods Mol Biol; 2010; 602():119-34. PubMed ID: 20012396
[TBL] [Abstract][Full Text] [Related]
10. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes.
Zaccone P; Fehérvári Z; Jones FM; Sidobre S; Kronenberg M; Dunne DW; Cooke A
Eur J Immunol; 2003 May; 33(5):1439-49. PubMed ID: 12731071
[TBL] [Abstract][Full Text] [Related]
11. NK cells and type 1 diabetes.
Rodacki M; Milech A; de Oliveira JE
Clin Dev Immunol; 2006; 13(2-4):101-7. PubMed ID: 17162353
[TBL] [Abstract][Full Text] [Related]
12. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.
Hong S; Wilson MT; Serizawa I; Wu L; Singh N; Naidenko OV; Miura T; Haba T; Scherer DC; Wei J; Kronenberg M; Koezuka Y; Van Kaer L
Nat Med; 2001 Sep; 7(9):1052-6. PubMed ID: 11533710
[TBL] [Abstract][Full Text] [Related]
13. The role of interferon alpha in initiation of type I diabetes in the NOD mouse.
Li Q; McDevitt HO
Clin Immunol; 2011 Jul; 140(1):3-7. PubMed ID: 21592863
[TBL] [Abstract][Full Text] [Related]
14. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL
J Immunol; 1995 Jan; 154(1):180-91. PubMed ID: 7995938
[TBL] [Abstract][Full Text] [Related]
15. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
16. Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.
Serreze DV; Chen YG
Trends Immunol; 2005 Nov; 26(11):603-7. PubMed ID: 16140038
[TBL] [Abstract][Full Text] [Related]
17. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
Batoulis H; Addicks K; Kuerten S
Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
[TBL] [Abstract][Full Text] [Related]
18. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
Lee MH; Lee WH; Todorov I; Liu CP
J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
[TBL] [Abstract][Full Text] [Related]
19. The role of innate immune responses in autoimmune disease development.
Waldner H
Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
[TBL] [Abstract][Full Text] [Related]
20. Can NK cells be a therapeutic target in human type 1 diabetes?
Dotta F; Fondelli C; Falorni A
Eur J Immunol; 2008 Nov; 38(11):2961-3. PubMed ID: 18979518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
